- Active Ingredients
Product Documentation
-
View RMM (Ibandronic acid - Patient Reminder Card - Cancer-related conditions)
Last updated on this site: 10 May 2024
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintIbandronic acid Accord 6mg concentrate for solution for infusion
- PL Number:
- EU/1/12/798/001-004
- MA Holder:
- Accord Healthcare S.L.U
- Product Classification:
-
POM
- Product Status:
- Active
Product Documentation
-
View Summary of Product Characteristics (SmPC - Ibandronic acid Accord 2mg, 6mg concentrate for solution for infusion)
Last updated on this site: 17 Jul 2023
Website administration update only- no change to file.
View Patient Information Leaflet (PIL - Ibandronic acid Accord 2mg, 6mg concentrate for solution for infusion)Last updated on this site: 17 Jul 2023
Website administration update only- no change to file.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaint
For any further assistance, please get in touch.